Who are we?


Signup for

Online registration

Log in to register
your trial

Search a trial




van CCT (UK)

van CCT (UK)

The treatment of depressive disorders with online psychological treatment supported by a clinician

- candidate number19352
- NTR NumberNTR4757
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR25-aug-2014
- Secondary IDsNL80-83910-98-12010 
- Public TitleThe treatment of depressive disorders with online psychological treatment supported by a clinician
- Scientific TitleBLENded care for Depressive symptoms IN General practice
- hypothesisThe main aim is to evaluate the effectiveness of a blended behavioral activation intervention or the offering of psychological care using an e-health program blended with support offered by the mental health worker of the general practice (in Dutch POH-GGz). In a randomized controlled trial, we will examine whether such blended treatment has additional value compared to care as usual which frequently constitutes antidepressants alone.
- Healt Condition(s) or Problem(s) studiedDepression, Depressive symptoms, Depressive disorders
- Inclusion criteriaIn order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Adult patients, i.e. aged 18 or over;
- Patients presenting to the GP with depressive disorder or depressive symptoms;
- Patients for whom a GP considers prescribing an antidepressant.
- Exclusion criteria- Severe depression requiring referral to specialized mental health service according to current guideline, e.g. acute suicidality
- Severe mental illness (current/past: schizophrenia, psychotic episode, bipolar disorder, depression with psychotic features)
• Anxiety disorder or obsessive compulsive disorder as primary diagnosis
- Current substance abuse (e.g. alcohol, drugs)
- Currently receiving treatment for depression (e.g. antidepressant medication, e-mental health intervention or psychological treatment)
- Insufficient command of the Dutch language
- No informed consent given
- No internet available or grossly insufficient computer skills
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingSingle
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-sep-2014
- planned closingdate1-sep-2018
- Target number of participants302
- InterventionsIntervention:
The intervention under study is a prescription to an online self-management program blended with a few direct contacts (face-to-face or telephonic) with a GP or POH-GGZ. This program will focus on depressive symptoms and it will be based on the principles of behavioral activation. The program will consist of six to eight modules with a recommended frequency of 1-2 times a week over 6-10 weeks in well-structured sessions with GP at two, four and six weeks (or delegated to POH-GGZ). All participating GPs will receive training on the use of the e-prescription.

Initiation of an antidepressant: the intention to start with antidepressant medication logically following the eligibility criteria. Consultations with GP will be arranged at two, four and six weeks (or delegated to POH-GGZ) and a prescription for antidepressant medication will be handed out. During the treatment the dose of the medication is allowed to be adjusted if necessary according to the GP.
- Primary outcomeReduction in symptoms of depression from baseline to the 3 months follow-up
- Secondary outcome1. Long-term outcome: reduction in symptoms of depression from baseline to 12 month follow-up
2. Percentage response
3. Remission at 3 and 12 months follow-up
4. Antidepressant use: number of prescriptions and dosage
5. Use of other psychotropics (such as benzodiazepines): number of prescriptions and dosage
6. Change from baseline to 3 and 12 months follow-up in functional impairment and activity limitation using the self-report
7. Health care utilization including visits to health care professionals (e.g. GP, psychologist, occupational physician) and use of the intervention and production loss
8. Change from baseline to 3 and 12 month follow-up in general health status
9. Treatment satisfaction to measure the user friendliness of the intervention.
- TimepointsBaseline, three months, six months and twelve months
- Trial web
- statusplanned
- Sponsor/Initiator University Medical Center Groningen (UMCG)
- Funding
(Source(s) of Monetary or Material Support)
ZON-MW, The Netherlands Organization for Health Research and Development
- Publications
- Brief summaryDepression is a common mental disorder that has a high disease and high economic burden. The majority of patients with mental health problems are treated by general practitioners (GPs). Guidelines recommend a stepped care approach for the treatment of these patients. This means that structured non-pharmacological interventions of low-intensity (e.g. brief psychological treatments) are recommended before starting antidepressants. However the dissemination of this approach is limited and it has been estimated that 70% of the cases are primarily treated with antidepressants. Time constraints and lack of familiarity with psychological treatments are probably key to this problem. In this randomized controlled trial we will study the effectiveness of an e-prescription for a blended care approach in the psychological treatment of participants with depression or depressive symptoms in the general practice compared to the intention to start an antidepressant. The e-prescription will be a prescription to an online self-management program based on the principles of behavioral activation blended with a few face-to- face or telephonic contacts with a GP or POH-GGZ (mental health worker of the general practice).

The primary objective is to evaluate if a blended behavioral activation intervention reduces depressive symptoms on the short term. Secondary objectives are to assess this additional value on long term outcomes, and to assess its effectiveness on percentage response, remission, treatment satisfaction, general health status, functional impairment and daily activities.
The second aim of this study is to examine the real-time experience of cognitions, emotions as well as behaviors during treatment by ecological momentary assessment (EMA). Compared to more conventional questionnaires, EMA has the advantage to reduce memory distortions. It also gives insight into actual experiences during treatment.

Study design
Pragmatic investigator blinded monocenter 1:1 randomized controlled trial

Study population:
Adult participants with a depressive disorder or depressive symptoms.

E-prescription of an online self-management program (one module per week spread over 5-10 weeks), blended with a few face-to- face or telephonic contacts with the GP or POH-GGZ.

Main study parameters/endpoints:
The main endpoint is the reduction in depressive symptoms as assessed by the Hamilton Depression Rating Scale-17 (HRSD-17) from baseline to three months after intervention. Secondary endpoints are the reduction on depressive symptoms using the HRSD-17 at 12 months, percentage response (50% reduction in symptoms on HRSD-17), remission (HRSD- 17 score below 7) at three and twelve months of follow-up, antidepressant use, effect on general health status, treatment satisfaction, functional impairment and daily activities as well as cost-effectiveness.
In addition to conventional questionnaires, we will capture real-time momentary ratings of cognitions and moods with so-called Ecological Momentary Assessment (EMA) in a sub- group of 60 participants. Specifically, using a smart phone application, auditory cue signals will be sent to participants’ mobile smartphones. Thereupon, participants will be asked to rate their momentary states of mood and distress, positive and negative affect as well as activity levels. Momentary states will be rated on visual analogue scales.
- Main changes (audit trail)12-mrt-2015: MET goedkeuring verkregen-EB
14-feb-2015: EB

Inclusion NEW:
- Patients for whom a GP wants to intensify the current therapy with medications, psychological therapy (GGz) or other

Intervention NEW:
Care as usual, with medical therapy or other as therapy.

Inclusion criteria:
“Patients for whom a GP considers prescribing an antidepressant”
Replaced by
“Patients with depressive symptoms or a depressive disorder for whom the GP or general practice mental health worker consider a second step in the treatment of depression after the first step of psycho-education and day-structuring exercises have yielded insufficient improvement.”

Exclusion criteria:
“Currently receiving treatment for depression (e.g. antidepressant medication, e- mental health intervention or psychological treatment)”
Replaced by
“Currently receiving psychological treatment for depression (e-mental health intervention or face-to- face psychological treatment)”

Secondary outcome NEW:
10. Ecological Momentary Assessment (EMA) or real-time ratings of momentary states of cognitions and moods every other day, 5 times per day at random moments, over the course of a 10-week period.
- RECORD25-aug-2014 - 29-apr-2017

  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar